Scientific Information

Scientific Programme

14:00-14:10

Welcome

Prof. F. Mecacci; Prof. H. Valensise

14:10-15:00

SESSION 1 - Methodology: how to collect data in a proper way

Chairman W. Gyselaers (I. Wilkinson)

14:10-14:30

Blood pressure measurement and/or hemodynamics assessment: what should we do?

W. Gyselaers

14:30-14:50

The role of POCUS in Maternal Medicine

J. Cornette

14:50-15:10

The Femtech Revolution-Reshaping and digitalizing women’s-Improving Global Maternal Offspring Outcome

M. Hod

15:10-15:20

Discussion

15:20-15:40

The modern maternal hemodynamic features for prediction of preeclampsia

Dmytro Konkov

Plasma renin concentration throughout healthy and hypertensive pregnancy: a systematic review and meta-analysis

Maaike van Ochten

On the pathogenesis of preeclampsia: a new pre-pregnancy risk factor for preterm and term preeclampsia and evidence from recurrences supporting their common origin.

Svitlana Arbuzova

15:40-16:00

Coffee break

16:00-17:30

SESSION 2 - Long term consequences

Chairman: B. Thilaganathan- C. Ghossein-Doha

16:00-16:20

Optimising maternal cardiovascular health outcomes in preeclampsia

B. Thilaganathan

16:20-16:40

Diversity in CV Medicine, beyond the gender perspective

C. Ghossein-Doha

16:40-17:00

Pre-eclampsia and long term cardiovascular morbidity: cause or association?

C. McEniery

17:00-17:10

Discussion

17:10-17:35

Early third trimester maternal cardiac morphometry in high-risk pregnancies of placental insufficiency

Judit Martinez-Egea

First trimester maternal hemodynamics in patients with or without chornic hypertension

Hyunyoung Ahn

Associations Between Blood Pressure Variability and Perinatal Outcomes

Natalia Boscaneanu

17:35-18:40

SESSION 3 - Hemodynamics in Fetal Growth restriction

Chairman: J. Cornette- H.Valensise

17:35-17:55

Preclinical hemodynamic profile in early and late FGR

B. Vasapollo

17:55-18:15

Modelling for prediction of outcome in Late FGR

R. Napolitano

18:15-18:25

Discussion

18:25-18:55

Postpartum maternal cardiac adaptation in SGA pregnancies and its correlation with biomarkers of cardiovascular risk

Eva Meler

Use of Antihypertensive Medications at Discharge and in the Immediate Postpartum Period: Observations from a Cohort of Hypertensive Pregnant Patients at a Canadian Tertiary Centre

Kelsey McLaughlin

Baroreceptor mediated blood pressure control in women with a history of preeclampsia

Nadine Boutkan

19:00

Cocktail

08:30-10:00

SESSION 4 - Basic research

Chairman: T. Mousa-C. McEniery

08:30-08:50

Oxygen and glucose supply in human fetal growth restriction

I. Cetin

08:50-09:10

Umbilical Venous flow and maternal hemodynamics

D. Farsetti

09:10-09:30

New predictors for hypertensive disorders of pregnancy

D.D. Di Martino

09:30-09:50

Does a mother’s heart know?

E. J Stohr

09:50-10:00

Discussion

10:00-10:30

The impact of obesity on maternal hemodynamics…

Pouya Abhari

Evaluating Trajectories of Placental Growth Factor (PlGF) and Pregnancy Outcomes Following Multimodal Screening for Preeclampsia.

John Snelgrove

Study protocol for the randomized controlled TREASURE trial: timely recovery after subclinical heart failure

Zenab Mohseni-Alsalhi

Early-life consequences of Hypertensive Disorders during Pregnancy: an exploration of the retinal microvasculature in young children.

Hanne Sleurs

10:30-11:00

Coffee Break

11:00-12:30

SESSION 5 - Labor

Chairman: H. Valensise

11:00-11:20

Fetal cardiac function in active labor

T. Ghi

11:20-11:40

Maternal hemodynamics during labor with epidural anesthesia

S. Giannubilo

11:40-12:00

Maternal hemodynamics in the delivery room

A. Dall’Asta

12:00-12:20

Fetal cardiac function: new tools

T. Stampalja

12:20-12:30

Discussion

12:30-13:00

Association between nadverse neonatal outocom and maternal haemodynamics

Christoph Lees

Preconception physical activity alters the cardiovascular profile of women at risk for gestational hypertensive disorders in a profile-specific way.

Pauline Dreesen

Arterial stiffness and endothelial function after preeclampsia: can they predict the outcome of the subsequent pregnancy?

Ellen Faes

Non-invasive maternal hemodynamics for the classification of pregnancies complicated by fetal growth restriction

Andrea Caricati

13:00-14:00

Light Lunch

14:00-15:50

SESSION 6 - Obstetric Anesthesia

Chairman: M. Micaglio, G.P. Novelli

14:00-14:20

Hemodynamic impact of neuraxial anesthesia for CS

M. Van de Velde (online)

14:20-14:40

Maternal Hemodynamic changes in pregnancy: what’s new?

L. Lorini

14:40-15:00

Update on fluid management in the pregnant patient

L. Frassanito

15:00-15:20

Homeostasis and noninvasive macrocirculation evaluation in pregnant patient

M. Micaglio

15:20-15:40

Cardiac output-guided maternal positioning might improve pregnancy outcomes

T. Archer

15:40-15:50

Discussion

15:50-17:00

SESSION 7 - Diabetes in Pregnancy

Chairman: F. Mecacci; Michael Paidas

15:50-16:10

Phenotipic eterogeneity of GDM: what is the relationship with the cardiovascular function

F. Mecacci

16:10-16:30

Routine mid gestation oral glucose tolerance test ‘plus’ to predict later preeclampsia

M. Spanderman

16:30-16:50

Changes in arterial stiffness among women with gestational diabetes

T. Mousa

16:50-17:00

Discussion

17:00-17:30

Coffee Break

17:30-19:00

SESSION 8 - Medical treatment in hypertensive disease: let’s have some help from hemodynamics

Chairman: M. Spanderman

17:30-17:50

Why management of PE must be tailored

C. Lees

17:50-18:10

Hypodynamic hypertension in pregnancy: update on treatment.

G.P Novelli

18:10-18:20

Why understanding pharmocokientics of anti hypertensive medications is important

I. Wilkinson

18:20-18:40

The potential of Pentaerytrithyltetranitrate PETN in pregnancies complicated by impaired placental perfusion and maternal hemodynamics

T. Groten

18:40-19:00

Maternal hemodynamics in GUCH pregnancies

F. Prefumo

19:00-19:10

Discussion

08:30-09:40

SESSION 9 - Twin pregnancy/IVF

Chairman: A. Khalil; F. Mecacci

08:30-08:50

Screening for preeclampsia in twin pregnancies

D. Schlembach

08:50-09:10

Hemodynamic and cardiac changes during twin vs singleton pregnancy

R. Orabona

09:10-09:30

Preeclampsia in twins how different from singletons

A. Khalil (online)

09:30-09:40

Discussion

09:40-10:20

Circulating Angiogenic Factors levels in women with Hypertensive Disorders of Pregnancy (HPD) according to the baseline hemodynamic findings

Beatrice Valentini

The correlation between first-trimester serum biochemical and biophysical markers and skin microvascular reactivity assessed by laser speckle contrast imaging

Mor Huri

Maternal and fetal hemodynamics assessment to predict IUGR in twin Pregnancies

Benedetta Lupoli

Small-for-gestational-Age Fetuses characteristics and outcome in pregnancies complicated by gestational diabetes

Sara Nardini (recorded)

Association between adverse neonatal outcome and maternal haemodynamics and biomarkers in SGA and FGR

Bronacha Mylrea-Foley

Physical activity during pregnancy: maternal hemodynamics and obstetrics outcomes

Anna Luna Tramontano

10:20-10:50

Coffee Break

10:50-11:20

The role of umbilical vein blood flow assessment in the prediction of fetal growth: a prospective observational cohort study

Daniele Farsetti

Haemodynamic evaluation in pregnancies complicated by T1DM (Type 1 Diabetes Mellitus): differences in LGA (Large for Gestational Age) vs AGA (Appropriate for Gestational Age) newborns

Benedetta Baggio

Maternal hemodynamics in placental implantation abnormalities: a pilot study

Filomena Maellaro

Hemodynamic and impedenzometric profile in low-risk pregnant women at term with excessive gestational weight gain. A pilot study

Teresa Aiolfi

11:20-12:30

SESSION 10 - HDP-Preeclampsia

Chairman: C. Lees- E. Ferrazzi

11:20-11:40

Do all women after HDP have the same long-term risk of CVD in later life?

J.J. Duvekot

11:40-12:00

Cardiovascular adaptations in Preeclampsia

M. Charakida

12:00-12:20

Discussion

12:20

Prize for the best oral presentation
Closing remarks

Accreditations

ECM – EDUCAZIONE CONTINUA IN MEDICINA

Numero di crediti assegnati: 5,4 crediti

 

Il Congresso sarà accreditato per le seguenti categorie:

Professione Discipline
MEDICOCHIRURGO
  • Neonatologia
  • Pediatria
  • Pediatria (Pediatri di libera scelta)
  • Ginecologia e Ostetricia
INFERMIERE
INFERMIERE PEDIATRICO
OSTETRICA/O

L’erogazione dei crediti ECM da parte del provider è subordinata a:

  1. alla partecipazione effettiva del 90% rispetto alla durata complessiva dell’evento formativo
  2. alla compilazione del questionario di gradimento online
  3. alla corrispondenza tra la professione svolta e le discipline dichiarate, dal provider, al momento della richiesta di accreditamento
  4. alla correttezza e completezza dei dati forniti su richiesta nella scheda anagrafica compilata.

AIFA – AGENZIA ITALIANA DEL FARMACO
Sarà effettuata la prerichiesta AIFA

UEMS – European Accreditation Council for CME (EACCME ®)
12.5 credits